MARKET

CLLS

CLLS

Cellectis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.82
+0.05
+0.27%
After Hours: 18.82 0 0.00% 16:00 02/21 EST
OPEN
18.57
PREV CLOSE
18.77
HIGH
18.91
LOW
18.18
VOLUME
179.31K
TURNOVER
--
52 WEEK HIGH
20.84
52 WEEK LOW
9.50
MARKET CAP
798.83M
P/E (TTM)
-9.0494
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CLLS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CLLS stock price target is 40.18 with a high estimate of 73.00 and a low estimate of 14.00.

EPS

CLLS News

More
  • Cellectis S.A. (CLLS) Moves to Strong Buy: Rationale Behind the Upgrade
  • Zacks · 1d ago
  • BTIG Research Maintains Buy on Cellectis, Raises Price Target to $39
  • Benzinga · 3d ago
  • Cellectis and Servier Expand Collaboration on UCART19 Products
  • Benzinga · 3d ago
  • Cellectis and Servier Expand Collaboration on UCART19 Products
  • Business Wire · 3d ago

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About CLLS

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. The Company also offers rational inverse genetics and targeting recombination tools. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.
More

Webull offers kinds of Cellectis SA (ADR) stock information, including NASDAQ:CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions.